Lexicon Pharmaceuticals, Inc. (LXRX)
PHARMACEUTICAL PREPARATIONS
Lexicon Pharmaceuticals, Inc. (LXRX) is listed on Nasdaq, where it has traded since April 7, 2000.
- Listed On
- Nasdaq
- Listed Since
- April 7, 2000
- Employees
- 81
- Market Cap
- $845M
About Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 145 institutions reported holding LXRX, with 364.6 million shares worth $875.0 million in aggregate. The largest reported holder was Artal Group, with 175.2 million shares worth $420.4 million. Of the 5 largest holders listed below, 4 added shares and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Artal Group | 175,156,062 | $420M | Added 13.2% |
| FMR | 51,782,045 | $124M | Added 14.93% |
| Siren, | 44,303,518 | $106M | Unchanged |
| Sessa Capital IM, | 18,960,836 | $46M | Added 5.85% |
| BlackRock | 17,348,741 | $42M | Added 422.2% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is LXRX?
Lexicon Pharmaceuticals, Inc. (LXRX) is listed on Nasdaq, where it has traded since April 7, 2000.
Who are the largest institutional holders of LXRX?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of LXRX were Artal Group, FMR and Siren,.
How many institutions own LXRX?
145 institutions reported a position in LXRX for the quarter ended June 30, 2026, worth $875.0 million in total.
Did institutions buy or sell LXRX last quarter?
Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for LXRX.
Every reported institutional holder, plus insider and congressional trades in LXRX, on SentiSense.